Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4 C
- 1 November 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 10 (8) , 687-693
- https://doi.org/10.1097/00008571-200011000-00003
Abstract
During the course of investigating the frequency of a CYP2A6 whole deletion-type polymorphism (CYP2A6*4C) in Japanese, an unexpectedly large population of heterozygotes for CYP2A6*4C and the wild-type (CYP2A6*1A) was found. Cloning of a cDNA encoding CYP2A6 from the liver of individuals judged as heterozygotes for CYP2A6*4C and the CYP2A6*1A was carried out to identify the causal allele(s) responsible for a possible overestimation. A clone isolated from the liver cDNA library possessed 58 bp sequences in the 3'-untranslated region, which was replaced with the corresponding region of the CYP2A7 gene. The same gene conversion existed in the genomic DNA, indicating that the replacement was not a cloning artifact. Based on the gene structure of the allele (CYP2A6*1B), this variant was thought to be one of the causal alleles responsible for overestimation of heterozygotes for CYP2A6*4C and CYP2A6* A. To investigate this further, we developed a genotyping method which could distinguish the CYP2A6*A, CYP2A6*1B and CYP2A6*4C alleles from each other. The results clearly showed that CYP2A6*1B was the sole allele responsible for the overestimation. We conclude that the new genotyping method allows determination of six genotypes of the CYP2A6 gene, simultaneously and precisely, in both Oriental and Caucasian populations.Keywords
This publication has 17 references indexed in Scilit:
- CYP2A6 Gene Deletion Reduces Susceptibility to Lung CancerBiochemical and Biophysical Research Communications, 1999
- Homologous Unequal Cross-Over within the Human CYP2A Gene Cluster as a Mechanism for the Deletion of the Entire CYP2A6 Gene Associated with the Poor Metabolizer PhenotypeThe Journal of Biochemistry, 1999
- The CYP2 A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesisPharmacogenetics, 1995
- Human Kidney Methoxyflurane and Sevoflurane MetabolismAnesthesiology, 1995
- Comparison of a novel thin-layer chromatographic—fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urineJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomesEuropean Journal of Biochemistry, 1991
- A tobacco smoke-derived nitrosamine, 4-(methytnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytocbrome P450s including the polymorphic human cytochrome P4502D6Carcinogenesis: Integrative Cancer Research, 1991
- Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.Proceedings of the National Academy of Sciences, 1990
- Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activityBiochemical Journal, 1990
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979